RVL Pharmaceuticals plc
RVLPQ
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -105.73% | 36.61% | -26.81% | -19.33% | -77.48% |
| Total Depreciation and Amortization | 1.08% | -7.00% | 5.26% | 4.40% | 2.25% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | 16.53% | 0.10% |
| Total Other Non-Cash Items | 190.34% | -20.82% | 773.91% | 79.59% | -184.87% |
| Change in Net Operating Assets | -402.46% | 118.53% | -208.54% | -76.95% | 236.97% |
| Cash from Operations | -107.32% | 64.60% | -62.75% | -605.86% | 115.03% |
| Capital Expenditure | 19.79% | -86.29% | -2,700.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | 10.13% | -85.04% | 106.25% | 349.12% | 54.05% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 21.71% | -612.21% | -174.46% | 305.26% | 470.00% |
| Total Debt Issued | -- | -- | -90.99% | -- | -- |
| Total Debt Repaid | 90.92% | -1,559.86% | 51.72% | 32.86% | -0.89% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 76.39% | -140.00% | -900.00% | 95.95% | -29.82% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 90.53% | -448.14% | -96.69% | 4,402.24% | -17.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.26% | 21.74% | -147.03% | 2,916.70% | 107.60% |